par Goldman, Michel ;Seigneuret, Nathalie;Eichler, Hans-Georg
Référence Nature reviews. Drug discovery, 14, 1, page (1-2)
Publication Publié, 2015
Article révisé par les pairs
Résumé : Since its launch in 2008, the Innovative Medicines Initiative has catalysed the formation of many consortia to address challenges in drug development and regulation. As it moves into its second phase, we highlight key outcomes so far and the lessons learned.